יום רביעי, כ״ט אב תשפ״וWednesday, August 12, 2026
Follow Us
Controlling off-target editing activity is one of the central challenges in making CRISPR-Cas9 technology accurate and applicable in medical practice.
“The CRISPR-IL consortium will enable Israeli industry to be at the forefront of genome editing worldwide."
August 7, 2026 
